Meet the Experts: Discussion About IPOs in the Biotech Industry




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Meet the Experts: Discussion About IPOs in the Biotech Industry
Released on: June 01, 2006. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton, CEO PharmaVentures, leads this month's international panel in a discussion about IPOs in the biotech industry, drawing on the wide-ranging experiences of our experts to address the practical realities that face companies hoping to enter the public market, and the options available for them to do so.
  • Summary
  • Participants
  • Company
Fintan Walton, CEO PharmaVentures, leads this month's international panel in a discussion about IPOs in the biotech industry, drawing on the wide-ranging experiences of our experts to address the practical realities that face companies hoping to enter the public market, and the options available for them to do so. Topics covered include current IPO market conditions in Europe, alternative IPO launch strategies and the knock-on effects that changes in the IPO market could have on early-stage funding.
Dr Michael Kauffman
CEO
Predix Pharmaceuticals

Robert Miller
CEO
Phynova

Charles Walker
Director
Nomura Code Securities
PharmaTelevision
PharmaTelevision® is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.